Literature DB >> 9989420

Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study.

O Ozaki1, K Ito, T Mimura, K Sugino, K Ito.   

Abstract

BACKGROUND AND OBJECTIVES: Although the prognosis of papillary thyroid carcinoma is favorable in most cases, recurrent disease in the regional lymph nodes is not uncommon, and some patients die of recurrent disease that ultimately becomes unresectable. We studied the proliferative activity of cancer cells in recurrent foci in lymph nodes to see whether repeated recurrences might result in anaplastic transformation of papillary thyroid carcinoma.
METHODS: Fourteen patients with papillary thyroid carcinoma who underwent reoperation for recurrent disease in the regional lymph nodes more than once were the subjects of the study. The histologic findings and proliferative activity of carcinoma foci at each recurrence were studied histologically and immunohistochemically.
RESULTS: There were higher incidences of histologic features of poorly differentiated thyroid carcinoma in the metastatic foci in the lymph nodes as it recurred repeatedly, and the labeling indexes of proliferating cell nuclear antigen (PCNA) and nuclear antigen Ki-67 (MIB-1) increased.
CONCLUSIONS: These observations suggest that papillary thyroid carcinoma may become more malignant, even undergo transformation to an anaplastic variety, as metastatic disease in the regional lymph nodes recurs repeatedly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989420     DOI: 10.1002/(sici)1096-9098(199901)70:1<45::aid-jso8>3.0.co;2-b

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Unusual types of thyroid cancer.

Authors:  K B Ain
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Mitsuhiro Fukushima; Hiroyuki Inoue; Tomonori Yabuta; Takashi Uruno; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Akira Miyauchi
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

4.  Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.

Authors:  Ji Hye Park; Hyeong Ju Kwon; Cheong Soo Park; SoonWon Hong
Journal:  Korean J Pathol       Date:  2014-06-26

5.  Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.

Authors:  M Onda; J Akaishi; S Asaka; J Okamoto; S Miyamoto; K Mizutani; A Yoshida; K Ito; M Emi
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

6.  Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.

Authors:  Junko Akaishi; Masamitsu Onda; Junichi Okamoto; Shizuyo Miyamoto; Mitsuji Nagahama; Kouichi Ito; Akira Yoshida; Kazuo Shimizu
Journal:  BMC Cancer       Date:  2006-11-01       Impact factor: 4.430

7.  The Ki67 index a prognostic marker in medullary thyroid carcinoma.

Authors:  L E Tisell; A Oden; A Muth; G Altiparmak; J Mõlne; H Ahlman; O Nilsson
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

Review 8.  Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.

Authors:  Rosalba Parenti; Lucia Salvatorelli; Gaetano Magro
Journal:  Int J Endocrinol       Date:  2014-07-01       Impact factor: 3.257

Review 9.  Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.

Authors:  Moira Ragazzi; Alessia Ciarrocchi; Valentina Sancisi; Greta Gandolfi; Alessandra Bisagni; Simonetta Piana
Journal:  Int J Endocrinol       Date:  2014-08-21       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.